Literature DB >> 26207928

Contrast Media for X-ray and Magnetic Resonance Imaging: Development, Current Status and Future Perspectives.

Thomas Frenzel1, Rüdiger Lawaczeck, Matthias Taupitz, Gregor Jost, Jessica Lohrke, Martin A Sieber, Hubertus Pietsch.   

Abstract

Over the last 120 years, the extensive advances in medical imaging allowed enhanced diagnosis and therapy of many diseases and thereby improved the quality of life of many patient generations. From the beginning, all technical solutions and imaging procedures were combined with dedicated pharmaceutical developments of contrast media, to further enhance the visualization of morphology and physiology. This symbiosis of imaging hardware and contrast media development was of high importance for the development of modern clinical radiology. Today, all available clinically approved contrast media fulfill the highest requirements for clinical safety and efficacy. All new concepts to increase the efficacy of contrast media have also to consider the high clinical safety standards and cost of goods of current marketed contrast media. Nevertheless, diagnostic imaging will contribute significantly to the progresses in medicine, and new contrast media developments are mandatory to address the medical needs of the future.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26207928     DOI: 10.1097/RLI.0000000000000193

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  3 in total

1.  The Effect of Patient Diameter on the Dual-Energy Ratio of Selected Contrast-Producing Elements.

Authors:  Jack W Lambert; Paul F FitzGerald; Peter M Edic; Yuxin Sun; Peter J Bonitatibus; Robert E Colborn; Benjamin M Yeh
Journal:  J Comput Assist Tomogr       Date:  2017 May/Jun       Impact factor: 1.826

2.  Effect of Repeated Injection of Iodixanol on Renal Function in Healthy Wistar Rats Using Functional MRI.

Authors:  Yongfang Wang; Ke Ren; Lizhi Xie; Wenge Sun; Yi Liu; Songbai Li
Journal:  Biomed Res Int       Date:  2018-04-04       Impact factor: 3.411

3.  Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging.

Authors:  James F Hainfeld; Sharif M Ridwan; Yaroslav Stanishevskiy; Nathaniel R Smilowitz; James Davis; Henry M Smilowitz
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.